Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor

Autor: Aida, Satoshi, Sonobe, Yukiko, Tanimura, Hiromi, Oikawa, Nobuhiro, Yuhki, Munehiro, Sakamoto, Hiroshi, Mizuno, Takakazu

Publikováno v: In Cancer Letters 28 November 2017 409:116-124

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations.

Autor: Aoki K; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Nishito Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Arai Y; Divison of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Hiraoka N; Department of Analytical Pathology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Shibata T; Divison of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Sonobe Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Kayukawa Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Hashimoto E; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Takahashi M; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Fujii E; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Nishizawa T; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Fukuda H; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Ohashi K; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Arai K; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Mizoguchi Y; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Yoshida Y; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Yamashita M; Advanced Medical Development Center, Cancer Research Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan., Kitano S; Advanced Medical Development Center, Cancer Research Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan., Sakamoto H; Department of Clinical Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Nagata Y; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.; Bioresource Research Center, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan., Mitsumori R; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan., Ozaki K; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan., Niida S; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan., Kanai Y; Department of Pathology, School of Medicine, Keio University, Sinjyuku-ku, Tokyo, Japan., Hirayama A; Institute for Advanced Biosciences, Keio University Tsuruoka, Yamagata, Japan., Soga T; Institute for Advanced Biosciences, Keio University Tsuruoka, Yamagata, Japan., Maruyama T; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Tsukada K; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Yabuki N; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Shimada M; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Kitazawa T; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Natori O; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Sawada N; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Kato A; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Yoshida T; Department of Genetic Medicine and Services, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Yasuda K; National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan., Mizuno H; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Tsunoda H; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan., Ochiai A; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan.

Publikováno v: Cancer research communications [Cancer Res Commun] 2023 Jun 13; Vol. 3 (6), pp. 1026-1040. Date of Electronic Publication: 2023 Jun 13 (Print Publication: 2023).